Publications by authors named "Nicole Bruchet"

Objective: Pharmacy student performance on practicum was previously assessed using a Likert scale from 0 to 9, resulting in challenges with clarity and assessor subjectivity. To address these issues, an assessment rubric based on the Dreyfus model of skill acquisition was developed and implemented. This study sought to evaluate student, practice educator (PE), and faculty perceptions related to the rubric's effectiveness in assessing student performance within the direct patient care practicum setting.

View Article and Find Full Text PDF

Background: Canadian pharmacy practice residency programs promote development of key competencies for direct patient care resulting in resolution of drug therapy problems (DTPs), which is 1 of 8 national clinical pharmacy key performance indicators. There are no Canadian data on the contribution of residents to resolution of DTPs, including DTPs for priority diseases covered in disease-state education modules (PD-DTPs) or quality indicator DTPs (QI-DPTs), as assessed through application of evidence-based interventions proven to reduce morbidity, mortality, or health resource utilization.

Objective: To describe the contribution of pharmacy practice residents to direct patient care using 3 process-of-care measures: resident-resolved DTPs, PD-DTPs, and QI-DTPs.

View Article and Find Full Text PDF

Background: Pharmacists in the intensive care unit (ICU) provide pharmaceutical care to critically ill patients. Identification and resolution of drug therapy problems improves outcomes for these patients. To maintain continuity of care, pharmacotherapy plans should be transferred to a receiving pharmacist upon discharge of patients from the ICU.

View Article and Find Full Text PDF

Introduction: Evaluations of behavior change interventions aimed at improving professional practice are increasingly focused on impacts at the practice and patient outcome levels. Many of these evaluations assume that if the intended changes occur, the result represents an improvement. However, given the systemic nature of clinical practice, a change in one area can produce changes in other areas as well, some of which may adversely affect the patient.

View Article and Find Full Text PDF

Background: Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil, a widely used immunosuppressant. Numerous studies have developed limited sampling strategies (LSSs) to predict MPA AUC in solid organ transplant recipients.

Objectives: To systematically review and assess quality of literature pertaining to MPA LSSs, evaluate clinical implications and provide suggestions for future research.

View Article and Find Full Text PDF